Loading asset research
Regentis Biomaterials Ltd. Ordinary Shares
RGNTNYSE · USD · StocksQuote as of · Exchange session not verified$1.89
-3.57%
Today
RGNT
Loading 1D prices…
Market cap
$13.3M
Volume
16.5K
52w high
$15.5052w low
$1.23Company profile
Regentis Biomaterials Ltd. Ordinary Shares
Regentis Biomaterials Ltd., a regenerative medicine company, develops and commercializes tissue repair solutions in the United States. It offers Gelrin, a platform based on hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen for the treatment and regeneration of damaged or diseased tissue; and GelrinC, a cell-free and off-the-shelf hydrogel, which is in Phase II clinical trial for the treatment of cartilage injuries in the knee. The company was incorporated in 2004 and is based in Herzliya, Israel.
Sector
Health Care
Industry
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Exchange
NYSE
Display currency
USD
Location
Herzliya, United States
Fiscal year end
1231
CIK
1912966
Session & valuation
Open$2.02
Previous close$1.96
Day high$2.02
Day low$1.89
30-day avg. volume49.8K
Outstanding shares5.2M
Diluted EPS-$24.16
Latest annual period
P/E (trailing)-0.08
P/E (forward)—
Price / book2.06
Beta—
Dividend yield—
Deterministic peer set
Companies with SEC SIC 3842
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| LFWDLifeward Ltd. Ordinary Shares | $20.2M | $1.4M | -1422.43% | -$17.16 | -0.14% | Buy |
| CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares | $8.4M | $38.8K | -9366.70% | -$1.83 | +5.00% | Unrated |
| CLGNCollPlant Biotechnologies Ltd Ordinary Shares | $6.6M | $2.4M | -484.56% | -$0.94 | -1.13% | Buy |
| MLSSMilestone Scientific Inc. Common Stock | $40.2M | $9M | +63.76% | -$0.07 | +3.26% | Buy |
| MYOMyomo Inc. Common Stock | $51.5M | $40.9M | -38.12% | -$0.37 | -1.54% | Buy |